Temsirolimus metabolic pathways revisited-Reference-Cited by-同舟云学术

Temsirolimus metabolic pathways revisited

Published:2019-10-23 Issue:6 Volume:50 Page:640-653
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Shokati Touraj¹²,Hartmann Marcel¹³,Davari Baharak¹,Klawitter Jost¹,Klawitter Jelena¹,Christians Uwe¹^ORCID

Affiliation:

1. iC42 Clinical Research and Development, Department of Anesthesiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;

2. Roche Diagnostics GmbH, Penzberg, Germany;

3. Zentrum für Zahn-, Mund- und Kieferheilkunde, Universität Greifswald, Greifswald, Germany

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2019.1678793

Reference28 articles.

1. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.

2. Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus

3. In Vitro Metabolic Study of Temsirolimus: Preparation, Isolation, and Identification of the Metabolites

4. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography–mass spectrometry with on-line extraction: immunosuppressants

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Characterization of Cannabichromene’s Major Metabolite Following Incubation with Human Liver Microsomes;Metabolites;2024-06-13

2. Structural Identification of Zotarolimus (ABT-578) Metabolites Generated by Human Liver Microsomes Using Ion-Trap and High-Resolution Time-of-Flight Mass Spectrometry in Combination with the Analysis of Fragmentation Patterns;Metabolites;2023-10-19

3. Three Layers of Personalized Medicine in the Use of Sirolimus and Its Derivatives for the Treatment of Cancer;Journal of Personalized Medicine;2023-04-27

4. The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients;Cancers;2022-03-18